Morphological features of IFN-γ–stimulated mesenchymal stromal cells predict overall immunosuppressive capacity
暂无分享,去创建一个
Ross A. Marklein | Cheng-Hong Wei | S. Bauer | M. Klinker | Jessica L Lo Surdo | Steven R Bauer | Matthew W Klinker | Ross A Marklein | Cheng-hong Wei | Jessica L. Lo Surdo
[1] D J Prockop,et al. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] Y. Li,et al. Negative regulation of interferon-γ/STAT1 signaling through cell adhesion and cell density-dependent STAT1 dephosphorylation. , 2011, Cellular signalling.
[3] O. Ringdén,et al. Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.
[4] Jean Imbert,et al. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. , 2006, Cytokine & growth factor reviews.
[5] D. Hursh,et al. In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter. , 2016, Cytotherapy.
[6] S. Bauer,et al. Global proteomic signature of undifferentiated human bone marrow stromal cells: evidence for donor-to-donor proteome heterogeneity. , 2013, Stem cell research.
[7] Sumona Sarkar,et al. Machine learning based methodology to identify cell shape phenotypes associated with microenvironmental cues. , 2016, Biomaterials.
[8] D. Prockop,et al. Methods and protocols. Preface. , 2008, Methods in molecular biology.
[9] John M Centanni,et al. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. , 2015, Cytotherapy.
[10] D. Prockop,et al. Mesenchymal Stem Cells. Methods and Protocols. , 2010, Anticancer research.
[11] S. Setty,et al. IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease , 2008, European journal of immunology.
[12] Ross A. Marklein,et al. Identification of Predictive Gene Markers for Multipotent Stromal Cell Proliferation. , 2016, Stem cells and development.
[13] F. Lanza,et al. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential. , 2011, Cytotherapy.
[14] T. Ritter,et al. Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: How well are we joining the dots? , 2013, Stem cells.
[15] Hiroyuki Honda,et al. Morphology-Based Prediction of Osteogenic Differentiation Potential of Human Mesenchymal Stem Cells , 2013, PloS one.
[16] D. Phinney. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy , 2012, Journal of cellular biochemistry.
[17] Glyn Stacey,et al. Soliciting Strategies for Developing Cell-Based Reference Materials to Advance Mesenchymal Stromal Cell Research and Clinical Translation , 2014 .
[18] K. Tarte,et al. Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal. , 2013, Cytotherapy.
[19] Matt J. Whitfield,et al. Onset of heterogeneity in culture-expanded bone marrow stromal cells. , 2013, Stem cell research.
[20] ViswanathanSowmya,et al. Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. , 2014 .
[21] K. English. Mechanisms of mesenchymal stromal cell immunomodulation , 2013, Immunology and cell biology.
[22] Bryan A. Millis,et al. Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells. , 2013, Cytotherapy.
[23] G. Nolan,et al. High-Dimensional Single Cell Analysis , 2014, Current Topics in Microbiology and Immunology.
[24] Jian-xin Lin,et al. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. , 2011, Current opinion in immunology.
[25] J. Galipeau,et al. IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells , 2014, The Journal of Immunology.
[26] E. Ortega,et al. Interferon gamma induces actin polymerization, Rac1 activation and down regulates phagocytosis in human monocytic cells. , 2012, Cytokine.
[27] M. Krampera,et al. Mesenchymal stem cells and autoimmune diseases. , 2011, Best practice & research. Clinical haematology.
[28] Joachim Kohn,et al. Cytoskeleton-based forecasting of stem cell lineage fates , 2009, Proceedings of the National Academy of Sciences.
[29] R. Puri,et al. MSC-based product characterization for clinical trials: an FDA perspective. , 2014, Cell stem cell.
[30] M Aguet,et al. The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.
[31] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[32] S. Bauer,et al. Chromosomal stability of mesenchymal stromal cells during in vitro culture. , 2016, Cytotherapy.
[33] Wong Cheng Lee,et al. Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency , 2014, Proceedings of the National Academy of Sciences.
[34] I. Sekiya,et al. Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality , 2002, Stem cells.
[35] D. Phinney. Biochemical Heterogeneity of Mesenchymal Stem Cell Populations: Clues to their Therapeutic Efficacy , 2007, Cell cycle.
[36] K. Keyvanfar,et al. Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency. , 2015, Cytotherapy.
[37] Jacques Galipeau,et al. The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria. , 2015, Cytotherapy.
[38] Todd C McDevitt,et al. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion. , 2014, Cytotherapy.
[39] A. Reinisch,et al. A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance , 2015, Stem Cell Research & Therapy.
[40] Nathan O. Loewke,et al. Dynamic and social behaviors of human pluripotent stem cells , 2015, Scientific Reports.
[41] D. Discher,et al. Mechanobiology of bone marrow stem cells: from myosin-II forces to compliance of matrix and nucleus in cell forms and fates. , 2013, Differentiation; research in biological diversity.
[42] Dennis E. Discher,et al. Physical plasticity of the nucleus in stem cell differentiation , 2007, Proceedings of the National Academy of Sciences.
[43] J. Galipeau,et al. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[44] Luis A Solchaga,et al. Prostaglandin E2: a putative potency indicator of the immunosuppressive activity of human mesenchymal stem cells. , 2012, American journal of stem cells.
[45] A. Ho,et al. Heterogeneity of mesenchymal stromal cell preparations. , 2008, Cytotherapy.
[46] I. Sekiya,et al. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. , 2001, Cytotherapy.
[47] A. Ventura,et al. The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation. , 2010, Cytotherapy.
[48] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[49] Ivan Martin,et al. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. , 2016, Cytotherapy.
[50] R. Tuan,et al. Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells , 2014, Stem cells.
[51] M. Klinker,et al. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. , 2015, World journal of stem cells.
[52] Ulrich Göbel,et al. bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use , 2004 .
[53] Sergio Romagnani,et al. Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .
[54] Sergio Romagnani,et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. , 2006, Stem cells.
[55] Sean X. Sun,et al. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single‐cell resolution , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] Allison Hubel,et al. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices , 2014, Transfusion.
[57] Abhishek Kumar,et al. Correlated spatio-temporal fluctuations in chromatin compaction states characterize stem cells. , 2013, Biophysical journal.
[58] K. V. Van Vliet,et al. Concise Review: When Colonies Are Not Clones: Evidence and Implications of Intracolony Heterogeneity in Mesenchymal Stem Cells , 2016, Stem cells.
[59] Ross A. Marklein,et al. High Content Imaging of Early Morphological Signatures Predicts Long Term Mineralization Capacity of Human Mesenchymal Stem Cells upon Osteogenic Induction , 2016, Stem cells.
[60] J. L. Surdo,et al. Toward Improved Characterization of Human Mesenchymal Stem Cells for Use in Cellular Therapies: A Regulatory Science Perspective , 2013 .
[61] R. Puri,et al. Gene markers of cellular aging in human multipotent stromal cells in culture , 2014, Stem Cell Research & Therapy.
[62] H. Kelchtermans,et al. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis , 2010, Arthritis research & therapy.